167 results
Page 3 of 9
8-K
EX-10.1
f7lat054uecfqe 1z0c1
1 Dec 21
Qualigen Therapeutics, Inc. Announces Closing of $8.82 Million Registered Direct Offering
3:39pm
424B5
mex 9ws97nx72j5o7nn
1 Dec 21
Prospectus supplement for primary offering
2:28pm
10-KT
93570tvb03pb51vyt3
31 Mar 21
Annual report (with FYE transition)
4:33pm
10-KT
EX-31.2
n2z9s
31 Mar 21
Annual report (with FYE transition)
4:33pm
10-KT
EX-31.1
cpojk2fb
31 Mar 21
Annual report (with FYE transition)
4:33pm
8-K
EX-10.1
azaupjou070s 05um
18 Dec 20
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
3:54pm
424B5
lxg5fqwihzh5jeh5jh
18 Dec 20
Prospectus supplement for primary offering
1:26pm